2019 saw a transition from investment to impact at SHPA, as we further strengthened our programs and services, our partnerships and our support for the professional community to give members the strongest base for satisfaction and success in hospital pharmacy.
President Peter Fowler and Chief Executive Kristin Michaels reflect on the year’s top moments and milestones in our 2019 Annual Report video.
THE Australian Government and Advanced Pharmacy Australia (AdPha) have broadly welcomed and endorsed the World Health Organization’s (WHO) new Pandemic Agreement, which lays out a coordinated global response against future outbreaks.
THE Therapeutic Goods Administration (TGA) has registered Kisunla (donanemab, Eli Lilly) for the treatment of adults with early symptomatic Alzheimer’s disease who have a specific genetic profile and the confirmed presence of amyloid plaque in the brain.
IN partnership with CARMEX
Notifications
